A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202)

Peter M. Voorhees, Vera J. Suman, Sascha A. Tuchman, Jacob P. Laubach, Hani Hassoun, Yvonne A. Efebera, Flora Mulkey, Misty Bova-Solem, Katelyn Santo, Destin Carlisle, Philip L. McCarthy, Paul G. Richardson

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A phase I/II study of ixazomib, pomalidomide, and dexamethasone for lenalidomide and proteasome inhibitor refractory multiple myeloma (Alliance A061202)'. Together they form a unique fingerprint.

Medicine & Life Sciences